HomeQuestion

What would you recommend as a subsequent therapy for patients with ROS-1 gene re-arrangement after progression on crizotinib?

1 Answers

Mednet Member

Medical Oncology · UCSD Moores Cancer Center

Clinical trial (entrectinib, repotrectinib) or lorlatinib

Register or Sign In to see full answer